Nω-hydroxy-l-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents
Authors:
- Andrei L. KleschyovAKAndrei L. Kleschyov
- Thomas MunzelTMThomas Munzel
- 15 June 2005
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 516 (3) , 260-267
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscleBiochemical Pharmacology, 2004
- Vasoprotection by nitric oxide: mechanisms and therapeutic potentialCardiovascular Research, 2002
- Oxidation of the Ketoxime Acetoxime to Nitric Oxide by Oxygen Radical-Generating SystemsNitric Oxide, 2001
- Pharmacological profile of nitrergic nerve-, nitric oxide-, nitrosoglutathione- and hydroxylamine-induced relaxations of the rat duodenum.Life Sciences, 2000
- Inhibition of Mn2+2-Arginase by Borate Leads to the Design of a Transition State Analogue Inhibitor, 2(S)-Amino-6-boronohexanoic AcidJournal of the American Chemical Society, 1997
- Mechanisms mediating the vasodilatory effects of N-hydroxy-l-arginine in coronary arteriesEuropean Journal of Pharmacology, 1996
- Nω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, Is a Strong Inhibitor of Liver and Macrophage ArginaseBiochemical and Biophysical Research Communications, 1994
- Formation of nitrogen oxides and citrulline upon oxidation of Nω-hydroxy-L-arginine by hemeproteinsBiochemical and Biophysical Research Communications, 1992
- Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideBiochemical and Biophysical Research Communications, 1989
- Redox cycling of resorufin catalyzed by rat liver microsomal NADPH-cytochrome P450 reductaseArchives of Biochemistry and Biophysics, 1989